Please Note - Streaming News is only available to subscribers to the Active Level and above
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Form 8.3 - Willis Towers Watson plc
RNS
RNS Number : 5176D
Citadel Group
28 October 2020
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
Citadel Group
Company dealt in
WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)
Common Stock ISIN IE00BDB6Q211
Date of dealing
27 October, 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
Long
Short
ISIN IE00BDB6Q211
Number (%)
Number (%)
(1) Relevant securities
197,987 (0.15%)
0 (0.00%)
(2) Derivatives (other than options)
1,638,427 (1.27%)
0 (0.00%)
(3) Options and agreements to purchase/sell
0 (0.00%)
0 (0.00%)
Total
1,836,414 (1.43%)
0 (0.00%)
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale
ISIN IE00BDB6Q211
Number of securities
Price per unit (Note 5)
Sell Transaction
10
201.6725 USD
Sell Transaction
16
201.6741 USD
Sell Transaction
30
202.9933 USD
Sell Transaction
100
204.9800 USD
Sell Transaction
100
203.8300 USD
Sell Transaction
46
202.9759 USD
Sell Transaction
91
201.7686 USD
Sell Transaction
140
201.7734 USD
Sell Transaction
295
203.5667 USD
Sell Transaction
442
203.5676 USD
Sell Transaction
488
202.5229 USD
Sell Transaction
746
202.5114 USD
Sell Transaction
20
202.8300 USD
Sell Transaction
21
204.0900 USD
Sell Transaction
122
202.7500 USD
Sell Transaction
31
202.8800 USD
Sell Transaction
40
204.3800 USD
Sell Transaction
100
204.0820 USD
Sell Transaction
126
202.7889 USD
Sell Transaction
4
202.2500 USD
Sell Transaction
14
201.4157 USD
Sell Transaction
19
201.6521 USD
Sell Transaction
22
201.8600 USD
Sell Transaction
31
202.3245 USD
Sell Transaction
60
202.1300 USD
Sell Transaction
63
202.3043 USD
Sell Transaction
75
200.5400 USD
Sell Transaction
91
201.1100 USD
Sell Transaction
100
201.8350 USD
Sell Transaction
100
200.8500 USD
Sell Transaction
117
201.8339 USD
Sell Transaction
167
201.9700 USD
Sell Transaction
315
201.2625 USD
Sell Transaction
353
202.1393 USD
Sell Transaction
422
201.9074 USD
Sell Transaction
1,256
201.8794 USD
Sell Transaction
1,458
202.4126 USD
DVP Transaction
72
201.9851 USD
DVP Transaction
274
200.4400 USD
RVP Transaction
291
200.4400 USD
RVP Transaction
10
203.8400 USD
RVP Transaction
10
202.3500 USD
RVP Transaction
10
203.8300 USD
RVP Transaction
10
201.2100 USD
RVP Transaction
10
202.0800 USD
RVP Transaction
5
200.4700 USD
Buy Transaction
428
200.4400 USD
Buy Transaction
306
202.4195 USD
Buy Transaction
250
203.6140 USD
Buy Transaction
250
201.6500 USD
Buy Transaction
141
202.0182 USD
Buy Transaction
71
200.5234 USD
Buy Transaction
65
200.5600 USD
Buy Transaction
54
201.9385 USD
Buy Transaction
1
201.4000 USD
Buy Transaction
1
200.5000 USD
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
ISIN IE00BDB6Q211
Nature of transaction
(Note 6)
Number of relevant securities
(Note 7)
Price per unit
(Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing,
varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type,
e.g. American, European etc.
Expiry date
Option money paid/ received per unit
(Note 5)
(ii) Exercising
Product name,
e.g. call option
Number of securities
Exercise price per unit
(Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction
(Note 8)
Details
Price per unit
(if applicable) (Note 5)
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None
Is a Supplemental Form 8 attached? (Note 9)
NO
Date of disclosure:
28 October, 2020
Contact name:
Julia Condon
Telephone number:
020 7645 9700
If a connected EFM, name of offeree/offeror with which connected
n/a
If a connected EFM, state nature of connection (Note 10)
n/a
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.